A Study of the Activity of Eculizumab for Prevention of Delayed Graft Function In Deceased Donor Kidney Transplant
Stopped After interim analysis, the pilot study was terminated and modified to a larger multicenter study (NCT01919346) to better assess efficacy.
Conditions
- Delayed Function of Renal Transplant
Interventions
- DRUG: Eculizumab
- DRUG: Placebo
Sponsor
Schroppel, Bernd, M.D.
Collaborators